Your search for digoxin returned 135 results

Your search for digoxin returned 135 results

Sort Results:

Relevant Recent
Drug Monograph

ZARBEE’S SLEEP WITH MELATONIN

L-theanine 50mg, gamma-aminobutyric acid 5mg, melatonin 5mg; per chewable tab; contains fructose, sugar, natural flavor, modified cellulose, ascorbic acid, stearic acid, honey, gum arabic, magnesium stearate, silicon dioxide, citric acid, stevia leaf extract (steviol glycosides), tartaric acid, malic acid, colors added (beta carotene, fruit juice & vegetable juice), guar gum; natural orange-flavor; alcohol-, dye-, and gluten-free.
News

Digoxin Ups Risk of Death in A-Fib, CHF Patients in Largest Study to Date

Previous research has yielded conflicting evidence on the use of digoxin in patient with atrial fibrillation (AF) or congestive heart failure (CHF), but the largest systematic review and meta-analysis suggests that there is an increased risk of all-cause mortality with digoxin use in these patients.
Drug News

Digoxin-Dronedarone Interaction Investigated

The use of digoxin in atrial fibrillation has remained controversial because of its narrow therapeutic window and its possible contribution to ventricular tachyarrhythmias and severe bradyarrhythmias.
News

Study Examines Hazard of Mortality for A-Fib Patients Receiving Digoxin

However, compared with patients not on digoxin, patients with a serum digoxin concentration ≥1.2 ng/mL had a 56% increased hazard of mortality (adjusted HR, 1.56; 95% confidence interval, 1.2 to 2.04). For each 0.5-ng/mL increase (P=0.001), there was a 19% higher adjusted hazard for death, and these results were similar in patients with and without heart failure.
Drug News

New Review Casts Doubt on Digoxin for Afib

A recent review on the role of digoxin in atrial fibrillation (AF) has concluded that clinicians should avoid using digoxin monotherapy for rate control in patients with AF when other options are available.
Uncategorized

Caraco Pharmaceutical recalls digoxin tablets

Caraco Pharmaceutical has issued a nationwide voluntary recall to the consumer level of all Caraco brand digoxin 0.125mg and 0.25mg tablets distributed prior to March 31, 2009, which are not expired and are within the expiration date of September 2011.
Generics News

Par Launches Generic Lanoxin

Par Pharmaceuticals announced that it has begun shipments of Digoxin Tablets, the generic version of Covis' Lanoxin.